ÑÇÐÇÓÎÏ·¹ÙÍø-www.yaxin868.com

ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾Ï³´²¹Ù·½ÍøÕ¾½ñÌìÊÇ£º2025-05-06Çл»³ÇÊÐ[È«¹ú]-ÍøÕ¾µØÍ¼
ÍÆ¼ö²úÆ· :
ÍÆ¼öÐÂÎÅ
¼¼ÊõÎÄÕµ±Ç°Î»ÖÃ:¼¼ÊõÎÄÕÂ>

ÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¶¨Á¿¼ì²âÊÔÖ½ÌõµÄÖÆ×÷·½·¨

ʱ¼ä:2025-05-06    ×÷Õß: ¹ÜÀíÔ±

רÀûÃû³Æ£ºÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¶¨Á¿¼ì²âÊÔÖ½ÌõµÄÖÆ×÷·½·¨
¼¼ÊõÁìÓò£º
±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖÓÃÓÚÐÂà©ßʶ¨Á¿¼ì²âµÄÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎöÊÔÖ½
^^ O
±³¾°¼¼Êõ£º
ĿǰµÄÃâÒß²ãÎö(lateral flow immunoassay£¬LFIA)¿ìËÙ¼ì²âÊÔÖ½Ìõ¶àÒÔ½ºÌå½ð¡¢²ÊÉ«È齺΢Á£»òÕßÓ«¹âËØ×÷Ϊ±ê¼ÇÎï¡£»ùÓÚ½ºÌå½ð±ê¼Ç¼¼Êõ¿ª·¢µÄ¿ìËÙ¼ì²â²úÆ·£¬´æÔÚÁéÃô¶ÈµÍ£¬Ö»Äܶ¨ÐÔ»òÕ߰붨Á¿£¬Åú¼ä²îÒì½Ï´óµÈÎÊÌ⣻²ÊÉ«È齺΢Á£ËäÈ»Åú¼ä²îÓÐËù¸Ä½ø£¬µ«ÁéÃô¶ÈÒÀÈ»½ÏµÍ£¬Ò²Ö»Äܶ¨ÐÔ»ò°ë¶¨Á¿£»»ùÓÚÓ«¹âËØ±ê¼Ç¼¼ÊõµÄÃâÒß²ãÎöÁéÃô¶ÈÓÐÁ˽ϴóÌá¸ß£¬Ò²ÄܽøÐж¨Á¿¼ì²â£¬µ«ÊÇÓÉÓÚÑù±¾Öк¬ÓнϸߵÄÓ«¹â±¾µ×Ðźţ¬ÇÒStockÎ»ÒÆ½ÏС£¬»á¶Ô¼ì²â²úÉú½Ï´óµÄÓ°Ï졣ʱ¼ä·Ö±æÓ«¹â(Time-resolved Fluorescence,TRF)ÊÇÒ»ÖÖ·ÇÍ¬Î»ËØÓ«¹â±ê¼ÇÎ ÓëÆÕͨӫ¹âÏà±È£¬¾ßÓÐStockÎ»ÒÆ´ó£¬Ó«¹âÊÙÃü³¤µÈÌØµã£¬¿ÉÒÔÓÐЧµÄ±ÜÃâÑùÆ·Öеı¾µ×Ó«¹â£¬ÒÔ¼°¼¤·¢¹âµÈÔÓÉ¢¹âµÄÓ°Ï죬Òò´ËÏà±ÈÆÕͨӫ¹â¾ßÓиü¸ßµÄÁéÃô¶ÈºÍ¿¹¸ÉÈÅÄÜÁ¦¡£±¾ÊµÓÃÐÂÐͽ«Ê±¼ä·Ö±æÓ«¹âÈ齺΢Çò±ê¼ÇºÍÃâÒß²ãÎöÁ½´ó¼¼Êõ½áºÏ£¬µÃµ½Ê±¼ä·Ö±æ·Ù¹âÃâÒß²ãÎö·¨(Time-resolved Fluorescence lateral flow immunoassay, TRF-LFIA)£¬¿ª·¢³öÄܹ»¾«È·¶¨Á¿µÄ¿ìËÙÃâÒß²ãÎö¼ì²âÊÔÖ½Ìõ¡£Í¬Ê±£¬±¾ÊµÓÃÐÂÐͶÔÓÚ´«Í³µÄÃâÒß²ãÎöĤ×éºÏ·½Ê½½øÐÐÁ˸Ľø£¬½«Ô­ÓеÄËIJãÉõÖÁÎå²ãĤϵͳ¸Ä±ä³ÉÈý²ãĤϵͳ¡£´«Í³µÄÃâÒß²ãÎöĤ×éºÏ·½Ê½°üÀ¨ÑùÆ·µæ¡¢ÂËѪĤ¡¢½áºÏµæ¡¢·ÖÀëĤ(ÏõËáÏËÎ¬ËØÄ¤)¡¢ÎüË®µæµÈËĵ½Îå²ã(ËIJãÔòûÓÐÂËѪ¹¦ÄÜ»òÕß½«ÂËѪ¹¦ÄÜÓëÑùÆ·µæ¹¦ÄÜ×éºÏ)¡£GE¹«Ë¾ÆìÏÂWhatman¿ª·¢Á˾ßÓÐÎåºÏÒ»¹¦ÄܵÄĤFuSion5£¬¼¯ºÏÁËÉÏÊöÎåÖÖĤµÄ¹¦ÄÜ£¬µ«Fusi0n5ÓÉÓÚ¿×¾¶½Ï´ó£¬¿¹ÌåÄÑÒԹ̶¨£¬ÐèÒªÖÆ±¸ÌØÊâµÄMoneÓÃÓڹ̶¨¿¹Ì壬Éú²ú¹¤ÒÕ½ÏΪ¸´ÔÓ£¬ÒÇÆ÷É豸ҪÇó½Ï¸ß£¬¿ª·¢µÄÃâÒß²ãÎöÊÔ¼ÁÖ»ÄÜÓÃÓÚ¶¨ÐÔ¼ì²â¡£±¾ÊµÓÃÐÂÐÍÀûÓÃFUsi0n5Ìæ´ú´«Í³µÄÑùÆ·µæ¡¢ÂËѪĤ¡¢½áºÏµæ£¬½«Ô­ÓеÄËIJãÉõÖÁÎå²ãĤϵͳ¼ò»¯£¬¿ª·¢³öÖ»ÐèÒªÈý²ãĤ½á¹¹µÄ¿ìËÙ¶¨Á¿ÃâÒß²ãÎö¼ì²âÊÔÖ½£¬²»½öʹÉú²ú¹¤Òյõ½Á˼ò»¯£¬²¢ÓÐЧµÄ½µµÍÁ˲úÆ·µÄÅúÄÚ²îºÍÅú¼ä²î£¬¼«¾ßʵÓüÛÖµ¡£

ʵÓÃÐÂÐÍÄÚÈݱ¾ÊµÓÃÐÂÐ͵ÄÄ¿µÄÊÇÌṩһÖÖÐÂÐ͵Ä¡¢ÄÜ¿ìËÙ¶¨Á¿¼ì²âÐÂà©ßʵÄÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¼ì²âÊÔÖ½Ìõ¡£±¾ÊµÓÃÐÂÐ͵ļ¼Êõ·½°¸ÎªÒ»ÖÖÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¶¨Á¿¼ì²âÊÔÖ½Ìõ£¬ °üÀ¨Fusi0n5Ĥ¡¢ÏõËáÏËÎ¬ËØÄ¤ÒÔ¼°ÎüˮֽÈý²¿·Ö£¬ÏõËáÏËÎ¬ËØÄ¤Î»ÓÚÖм䣬Fusi0n5ĤÓëÎüˮֽ·Ö±ð´î½ÓÓÚÏõËáÏËÎ¬ËØÄ¤×óÓÒÁ½¶Ë£¬Fusion5ĤÉÏÉèÓмÓÑùÇøºÍ΢ÇòÇø£¬ÏõËáÏËÎ¬ËØÄ¤ÉÏÉèÓаü±»ÓÐÐÂà©ßÊ¿¹Ô­µÄ¼ì²âÏß(TÏß)ºÍ°ü±»ÓÐÇ׺ÍËØ»òÁ´Ã¹Ç׺ÍËØµÄÖÊ¿ØÏß(C Ïß)¡£[0011]¸ÃÊÔÖ½ÌõFusi0n5ĤÉÏÔ¶ÀëÏõËáÏËÎ¬ËØÄ¤µÄÒ»¶ËÉèÓмÓÑùÇø£¬½Ó½üÏõËáÏËÎ¬ËØÄ¤µÄÇøÓòÉèÓÐ΢ÇòÇø¡£ËùÊö΢ÇòÇøÉÏÔØÓÐʱ¼ä·Ö±æÓ«¹â΢Çò£¬°üÀ¨¼ì²â΢ÇòºÍÖÊ¿ØÎ¢Çò£¬¼ì²â΢ÇòΪ±íÃæ°ü±»ÓÐÐÂà©ßÊ¿¹ÌåµÄÓ«¹â΢Çò£¬ÖÊ¿ØÎ¢ÇòΪ±íÃæ°ü±»ÓÐÉúÎïËØ±ê¼Çµ°°×µÄÓ«¹â΢Çò¡£½øÒ»²½µÄ£¬ËùÊöÐÂà©ßÊ¿¹Ô­ÎªÐÂà©ßʵľºÕùÐÔ¿¹Ô­£»½Ï¼ÑµÄ£¬ËùÊöÐÂà©ßʵľºÕùÐÔ¿¹Ô­ÎªÐÂà©ßÊ¿¹Ô­¸´ºÏÎï¡£ÐÂà©ßÊ¿¹ÌåΪÐÂà©ßʵĵ¥¿Ë¡¿¹Ìå»ò¶à¿Ë¡¿¹Ìå¡£ÓÅÑ¡µÄ£¬ËùÊöʱ¼ä·Ö±æÓ«¹â΢ÇòÁ£¾¶·¶Î§Îª100 lOOOnm¡£ËùÊöÓ«¹â΢ÇòÖÐÌî³äÁËïçÏµÔªËØ»¯ºÏÎ½ÏÓŵ쬏ÃïçÏµÔªËØòüºÏÎïΪîðòüºÏÎ ×îÓŵ쬏ÃîðòüºÏÎï¿ÉΪEu (TTA) 3/¦³0¦±0»òEu (TTA) 3/Wien¡£ËùÊöÉúÎïËØ±ê¼Çµ°°×¿ÉÒÔÊÇÈκÎÒ»ÖÖ²»Ó°ÏìÉúÎïËØ/Á´Ã¹ÉúÎïËØÓëÇ׺ÍËØµÄ½áºÏ£¬²¢¿É±»ÉúÎïËØ±ê¼ÇµÄµ°°×¡£½ÏÓŵģ¬ËùÊöµ°°×¿ÉÒÔÊÇţѪÇåY-Çòµ°°×(BGG)»òСţѪÇå°×µ°°×(BSA)¡£ÏõËáÏËÎ¬ËØÄ¤ÉÏ£¬TÏߺÍCÏßÏ໥ƽÐУ¬TÏß¿¿½ü¼ÓÑù¿×¶Ë£¬CÏßÔ¶Àë¼ÓÑù¿×¶Ë¡£ÓÅÑ¡µÄ£¬ËùÊöʱ¼ä·Ö±æÓ«¹âÃâÒß¶¨Á¿¼ì²âÊÔÖ½Ìõµ×²¿ÉèÓÐËÜÁϵװå¡£±¾ÊµÓÃÐÂÐ͵ÄÐÂà©ßÊÊÔÖ½Ìõͨ¹ý¾ºÕù·¨Ô­Àí²â¶¨ÐÂà©ßÊ¡£ÊµÑé֤ʵ£¬±¾ÊµÓÃÐÂÐ͵ÄÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎöÊÔÖ½ÌõÁéÃô¶È¸ß£¬ÅúÄڲÅú¼ä²îС£¬ÓнϺõÄÖØ¸´ÐÔ£¬¿Éͬʱ¼ì²âȫѪ¡¢ÑªÇ塢Ѫ½¬¡¢ÄòÒºÑù±¾£¬250mg/dLѪºìµ°°×¡¢500mg/dL¸ÊÓÍÈýõ¥¡¢10mg/dLµ¨ºìËØ¶Ô±¾ÊµÓÃÐÂÐ͵ÄÊÔÖ½ÌõµÄ¼ì²âÎÞÓ°Ï죬Զ³¬¹ýÊг¡ÉÏ´ó¶àÊýÃâÒß²ãÎö¿ìËÙÕï¶Ï²úÆ·¡£

ͼ1 ±¾ÊµÓÃÐÂÐÍÐÂà©ßÊÊÔÖ½Ìõ½á¹¹Ê¾Òâͼ(1.ËÜÁϵװå 2.Fusi0n5Ĥ 3.ÏõËáÏËÎ¬ËØÄ¤4.Îüˮֽ5.¼ÓÑùÇø6.΢ÇòÇø7. TÏßÇø8. CÏßÇø)ͼ2 ÐÂà©ßÊÊÔÖ½Ìõ¼ì²â±ê×¼ÇúÏß
¾ßÌåʵʩ·½Ê½
Èçͼ1ËùʾµÄÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¶¨Á¿¼ì²âÊÔÖ½Ìõ£¬°üÀ¨FUsi0n5Ĥ2¡¢ ÏõËáÏËÎ¬ËØÄ¤3ÒÔ¼°Îüˮֽ4Èý²¿·Ö¡£ÏõËáÏËÎ¬ËØÄ¤Î»ÓÚÖм䣬Fusi0n5ĤÓëÎüˮֽ·Ö±ð´î½ÓÓÚÏõËáÏËÎ¬ËØÄ¤×óÓÒÁ½¶Ë£¬Õ³ÌùÔÚ´øÓб³½ºµÄËÜÁϵװå1ÉÏ¡£Fusion5ĤÉÏÔ¶ÀëÏõËáÏËÎ¬ËØÄ¤µÄÒ»¶ËÉèÓмÓÑùÇø5£¬½Ó½üÏõËáÏËÎ¬ËØÄ¤µÄÇøÓòÉèÓÐ΢ÇòÇø6£¬Î¢ÇòÇøÉÏÔØÓÐʱ¼ä·Ö±æÓ«¹â΢Çò£¬°üÀ¨¼ì²â΢ÇòºÍÖÊ¿ØÎ¢Çò£¬ËùÊö¼ì²â΢ÇòΪ±íÃæ°ü±»ÓÐÐÂà©ßʵ¥¿Ë¡¿¹ÌåµÄÓ«¹â΢Çò£¬ÖÊ¿ØÎ¢ÇòΪ±íÃæ°ü±»ÓÐÉúÎïËØ±ê¼Çµ°°× (Y-Çòµ°°×(BGG))µÄÓ«¹â΢Çò£»ÏõËáÏËÎ¬ËØÄ¤ÉÏÉèÓÐTÏß7ºÍCÏß8£¬Á½ÌõÏßÏ໥ƽÐУ¬T Ïß¿¿½ü¼ÓÑù¿×¶Ë£¬ÆäÉϰü±»ÐÂà©ßÊ¿¹Ô­¸´ºÏÎCÏßÔ¶Àë¼ÓÑù¿×¶Ë£¬ÆäÉϰü±»Á´Ã¹Ç׺ÍËØ¡£½øÒ»²½µÄ£¬ËùÊöʱ¼ä·Ö±æÓ«¹â΢ÇòÁ£¾¶·¶Î§Îª100 lOOOnm¡£ÉÏÊöÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒßÊÔÖ½ÌõµÄÖÆ±¸¼°Ê¹ÓÃÈçÏÂ1.ÊÔÖ½Ìõ¸÷³É·ÖµÄ×¼±¸11ÖÊ¿ØÎ¢ÇòµÄÖÆ±¸ÉúÎïËØ±ê¼ÇY-Çòµ°°×(BGG)°ü±»µÄÖÊ¿ØÎ¢ÇòµÄÖÆ±¸(1)ÉúÎïËØ±ê¼ÇµÄBGGµÄÖÆ±¸[0030]Óà 0. IM NaCNBH3 ½« BGG (¹º×Ô Pel-Freez Biological)ÅäÖÆ³É 10mg/ml ÈÜÒº£¬²ÉÓÃDMSO( ¶þ¼×»ù¼×õ£°·)ÅäÖÃBiotin-X-X-NHS (N-ôÇ»ùçúçêõ£Ñǰ·ÐÞÊÎÉúÎïËØ£¬Éú²úÉÌ SIGMA£¬²úÆ·ºÅB3295)ÈÜÒºÖÁ 16. 172mg/ml£¬°´ÕÕ ImgBGG µ°°×¼ÓÈë 5. 4ulBiotin-X-X_NHS µÄÁ¿½«Biotin-X-X-NHSÒº¼ÓÈëµ½BGGÈÜÒºÖУ¬»ìºÏ¾ù„ò²¢ÔÚ4¡ãCÏ·ÅÖùýÒ¹¡£²ÉÓÃ͸Îö·¨³ýÈ¥ÓÎÀëδ·´Ó¦µÄÉúÎïËØ£¬Í¸ÎöҺΪÉúÎïËØ±ê¼Çµ°°×͸Îö»º³åÒº(0. IM Tris,0. 3M NaCl, 0. 005M EDTA-Na-2H20, pH 8. 0)¡£Í¸ÎöÍê±Ï£¬BCA·¨²â¶¨µ°°×Ũ¶È¡£ (2)²ÉÓÃÉÏÊö±ê¼Çµ°°×°ü±»È©»ùÐÞÊεÄÓ«¹â΢ÇòÏòIOmgÈ©»ùÐÞÊεÄÓ«¹â΢Çò(²©ÑôÉúÎï¿Æ¼¼(ÉϺ£)ÓÐÏÞ¹«Ë¾)ÖмÓÈë 6.4¦Ì 120%µÄTween-20ÈÜÒº¡¢2mgÉÏÊö(1)ÖÐ͸ÎöµÃµ½µÄÉúÎïËØ±ê¼Çµ°°×ÒÔ¼°16 ¦Ì 1µÄ NaCNBH3 (25mg/ml£¬0. 05M pH6. 0µÄMES»º³åÒºÅäÖÆ£¬ÏÖÅäÏÖÓÃ)£¬²¹¼Ó0. IM pH6. OMESÖÁ×ÜÌå»ýΪ 400 ¦Ì 1£¬37¡ã ±Ü¹â·õÓý 48h¡£¼ÓÈë 40¦Ì 1 µÄ Gly ÈÜÒº(75mg/ml£¬0. 05M pH6. 0 µÄ MES »º³åÒºÅäÖÆ)£¬37¡ã±Ü¹âÐýת·´Ó¦2h¡£¼Ó250¦Ì1 BSA(200mg/ml,0. 05M pH6. 0µÄMES»º³åÒºÅäÖÆ)ÈÜÒº¡£37¡ã±Ü¹âÐýת·´Ó¦16h¡£4¡ãC 13000gÀëÐÄ30·ÖÖÓ¡£ÆúÉÏÇ壬ÓÃIml pH6. 0µÄ MES »º³åÒºÔÙÏ´Á½´Î¡£Óà Iml 0. 05M pH8. 0 µÄ HEPES »º³åÒº(50mMHEPES£¬300mM NaCl,25mM EDTA-Na-2H20,1. 6% BSA, 0. 1 % Dextran, 0. 1 % Tween-20,0. 3745 % TritonX-405,0. 01 % Çì´óÃ¹ËØ£¬0. 05% Proclin)Ðü¸¡(ÆäÖÕŨ¶ÈΪ10mg/ml)¡£(3)ÖÊ¿ØÎ¢Çò¹¤×÷ÒºÅäÖÆ¸ù¾Ý¹¤×÷ÐèÒª£¬²ÉÓÃ0. 05M pH8. 0µÄHEPES»º³åÒº½«¢ÆÖÐÐüҺϡÊ͵½ÏàӦŨ¶È£¬ ·Ö×°±£´æ¡£1. 2¼ì²â΢ÇòµÄÖÆ±¸ÏòIOmgÈ©»ùÐÞÊεÄÓ«¹â΢Çò(²©ÑôÉúÎï¿Æ¼¼(ÉϺ£)ÓÐÏÞ¹«Ë¾)ÖмÓÈë6. 4 ¦Ì 1 20% µÄ Tween-20 ÈÜÒº¡¢2mg ÐÂà©ßʵ¥¿Ë¡¿¹ÌåÒÔ¼° 16 ¦Ì 1 µÄ NaCNBH3 Q5mg/ml£¬0. 05M pH6. 0 µÄMES»º³åÒºÅäÖÆ£¬ÏÖÅäÏÖÓÃ)£¬²¹¼Ó0. IM pH6. OMESÖÁ×ÜÌå»ýΪ400 ¦Ì 1£¬37¡ã±Ü¹â·õÓý 48h¡£¼ÓÈë40 ¦Ì 1µÄGlyÈÜÒº(75mg/ml,0. 05M ¦Ñ¦§6¡¤ 0µÄMES»º³åÒºÅäÖÆ)£¬37¡ã±Ü¹âÐýת·´Ó¦2h¡£¼Ó250 ¦Ì 1 BSA(200mg/ml,0. 05M ¦Ñ¦§6¡¤ 0µÄMES»º³åÒºÅäÖÆ)ÈÜÒº¡£37¡ã±Ü¹âÐýת·´Ó¦16h¡£4¡ãC 13000gÀëÐÄ30·ÖÖÓ¡£ÆúÉÏÇ壬ÓÃIml pH6. 0µÄMES»º³åÒºÔÙÏ´Á½´Î¡£ÓÃIml 0.05M ¦Ñ¦§8¡¤ 0 µÄ HEPES »º³åÒº(50mM HEPES,300mM NaCl,25mM EDTA-Na-2H20,1. 6% BSA, 0. 1% Dextran,0. 1 % Tween-20,0. 3745% TritonX-405,0. 01%Çì´óÃ¹ËØ£¬0. 05% Proclin) Ðü¸¡(ÆäÖÕŨ¶ÈΪ10mg/ml)¡£1. 3΢ÇòÈÜÒºµÄÅäÖÃÓÃÊÍ·Å»º³åÒº(º¬ÓÐ20%ÕáÌÇ¡¢5%º£ÔåÌÇ¡¢0.5% BSA¡¢0. 2%Çì´óÃ¹ËØ)½«ÖÊ¿ØÎ¢ÇòºÍ¼ì²â΢ÇòÅäÖÆ³Éʱ¼ä·Ö±æÓ«¹â΢Çò»ìºÏÒº£¬ÖÊ¿ØÎ¢ÇòÖÕŨ¶ÈΪ0. 2mg/ml£¬¼ì²â΢ÇòÖÕŨ¶ÈΪlmg/ml¡£1. 4¼ì²âÏß(TÏß)ÈÜÒºµÄÅäÖÆÓÃIOmM PBÈÜÒº½«ÐÂà©ßÊ¿¹Ô­¸´ºÏÎïÏ¡ÊͳÉ0. 5mg/ml¡£1. 5ÖÊ¿ØÏß(CÏß)ÈÜÒºµÄÅäÖÆÓÃIOmM PBÈÜÒº½«Á´Ã¹Ç׺ÍËØÏ¡ÊͳÉ0. 5mg/ml¡£2.ÊÔÖ½ÌõµÄÖÆ±¸2.1¿Õ°×´ó¿¨Õ³Ìù[0045]°´ÕÕ¸½Í¼1µÄĤ×éºÏ·½Ê½£¬ÏõËáÏËÎ¬ËØÄ¤3λÓÚÖм䣬Fusi0n5Ĥ2ÓëÎüˮֽ4·Ö±ð´î½ÓÓÚÏõËáÏËÎ¬ËØÄ¤×óÓÒÁ½¶Ë£¬Õ³ÌùÔÚ´øÓб³½ºµÄËÜÁϵװåÉÏ¡£2. 2 ÅçĤ·Ö±ðÔÚͼ1ÖÐTÏß7¡¢CÏß8λÖÃÅçÉÏT¡¢CÏßÈÜÒº£¬C¡¢TÏßÅçĤҺÁ¿Îª¦©¦Ì /cm;ÔÚͼ1ÖÐ6λÖÃÅçÉÏ΢ÇòÈÜÒº£¬Î¢ÇòÈÜÒºÅçĤÁ¿Îª4 ¦Ì 1/cm¡£2. 3 ºæ¸É½«²½ÖèO)ÖÐÅçºÃÊÔ¼ÁµÄÐÂà©ßÊ´ó¿¨ÔÚºãκæÏäÖÐ37¡ãCºæ¸ÉMСʱ¡£2. 4 ÇÐÌõ½«ºæ¸ÉµÄÐÂà©ßÊ´ó¿¨Çиî³É4mm¿í¶ÈµÄÖ½Ìõ£¬¼´µÃµ½ÐÂà©ßÊÊÔÖ½Ìõ¡£3.ÊÔÖ½ÌõµÄ¶¨Á¿¼ì²â3.1»æÖƱê×¼ÇúÏßÔÚÖÆ±¸ºÃµÄÐÂà©ßÊÊÔÖ½Ìõ(ÅúºÅ20100821)¼ÓÑùÇøÖмÓÈ벻ͬŨ¶ÈµÄÐÂà©ßÊ¿¹Ô­±ê׼Ʒ(È¡Îå¸ö²»Í¬µÄŨ¶È£¬·Ö±ðΪ0¡¢l¡¢5¡¢10¡¢50ng/ml£¬Ã¿¸öŨ¶ÈÉè5¸öÖØ¸´)£¬µÎ¼ÓÉÏÑù»º³åÒº(PBS£¬º¬ÓÐ1. 6% BSA, 0. 1% Tween20,·À¸¯¼Á)£¬Ä¤²ãÎö10·ÖÖÓÒÔºó£¬ÒÇÆ÷¶ÁÈ¡C¡¢ TÏßÐźţ¬ÊµÑé½á¹û¼°·ÖÎö¼û±í1 :±í1ÐÂà©ßʱê׼Ʒ¼ì²â½á¹û
ȨÀûÒªÇó1.Ò»ÖÖÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¶¨Á¿¼ì²âÊÔÖ½Ìõ£¬ÆäÌØÕ÷ÔÚÓÚ£¬¸ÃÊÔÖ½Ìõ°üÀ¨ Fusion5Ĥ¡¢ÏõËáÏËÎ¬ËØÄ¤ÒÔ¼°ÎüˮֽÈý²¿·Ö£¬ÏõËáÏËÎ¬ËØÄ¤Î»ÓÚÖм䣬Fusion5ĤÓëÎüˮֽ·Ö±ð´î½ÓÓÚÏõËáÏËÎ¬ËØÄ¤×óÓÒÁ½¶Ë£¬Fusi0n5ĤÉÏÉèÓмÓÑùÇøºÍ΢ÇòÇø£¬ÏõËáÏËÎ¬ËØÄ¤ÉÏÉèÓаü±»ÓÐÐÂà©ßÊ¿¹Ô­µÄ¼ì²âÏߺͰü±»ÓÐÇ׺ÍËØ»òÁ´Ã¹Ç׺ÍËØµÄÖÊ¿ØÏß¡£
2.ÈçȨÀûÒªÇó1ËùÊöµÄÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¶¨Á¿¼ì²âÊÔÖ½Ìõ£¬ÆäÌØÕ÷ÔÚÓÚ£¬ FusionĤÉÏÔ¶ÀëÏõËáÏËÎ¬ËØÄ¤µÄÒ»¶ËÉèÓмÓÑùÇø£¬½Ó½üÏõËáÏËÎ¬ËØÄ¤µÄÒ»¶ËÉèÓÐ΢ÇòÇø£¬ ΢ÇòÇøÉÏÔØÓÐʱ¼ä·Ö±æÓ«¹â΢Çò¡£
3.ÈçȨÀûÒªÇó2ËùÊöµÄÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¶¨Á¿¼ì²âÊÔÖ½Ìõ£¬ÆäÌØÕ÷ÔÚÓÚ£¬ ËùÊöʱ¼ä·Ö±æÓ«¹â΢Çò°üÀ¨¼ì²â΢ÇòºÍÖÊ¿ØÎ¢Çò£¬¼ì²â΢ÇòΪ±íÃæ°ü±»ÓÐÐÂà©ßÊ¿¹ÌåµÄÓ«¹â΢Çò£¬ÖÊ¿ØÎ¢ÇòΪ±íÃæ°ü±»ÓÐÉúÎïËØ±ê¼Çµ°°×µÄÓ«¹â΢Çò¡£
4.ÈçȨÀûÒªÇó3ËùÊöµÄÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¶¨Á¿¼ì²âÊÔÖ½Ìõ£¬ÆäÌØÕ÷ÔÚÓÚ£¬ ËùÊöʱ¼ä·Ö±æÓ«¹â΢ÇòµÄÁ£¾¶·¶Î§Îª100 lOOOnm¡£
5.ÈçȨÀûÒªÇó1ËùÊöµÄÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¶¨Á¿¼ì²âÊÔÖ½Ìõ£¬ÆäÌØÕ÷ÔÚÓÚ£¬ ¼ì²âÏߺÍÖÊ¿ØÏßÏ໥ƽÐУ¬ÆäÖмì²âÏß¿¿½ü¼ÓÑù¿×¶Ë£¬ÖÊ¿ØÏßÔ¶Àë¼ÓÑù¿×¶Ë¡£
6.ÈçȨÀûÒªÇó1-5ÈÎһȨÀûÒªÇóËùÊöµÄÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¶¨Á¿¼ì²âÊÔÖ½Ìõ£¬ÆäÌØÕ÷ÔÚÓÚ£¬ÊÔÖ½Ìõµ×²¿ÉèÓÐËÜÁϵװå¡£
רÀûÕªÒª±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖÐÂà©ßÊʱ¼ä·Ö±æÓ«¹âÃâÒß²ãÎö¶¨Á¿¼ì²âÊÔÖ½Ìõ¡£¸ÃÊÔÖ½Ìõ°üÀ¨Fusion5Ĥ¡¢ÏõËáÏËÎ¬ËØÄ¤ºÍÎüˮֽÈý²¿·Ö£¬ÏõËáÏËÎ¬ËØÄ¤Î»ÓÚÖм䣬Fusion5ĤÓëÎüˮֽ·Ö±ð´î½ÓÓÚÏõËáÏËÎ¬ËØÄ¤×óÓÒÁ½¶Ë£¬Fusion5ĤÉÏÉèÓмÓÑùÇøºÍ΢ÇòÇø£»ÏõËáÏËÎ¬ËØÄ¤ÉÏÉèÓаü±»ÓÐÐÂà©ßÊ¿¹Ô­µÄ¼ì²âÏß(TÏß)ºÍ°ü±»ÓÐÇ׺ÍËØ»òÁ´Ã¹Ç׺ÍËØµÄÖÊ¿ØÏß(CÏß)¡£±¾ÊµÓÃÐÂÐ͵ÄÐÂà©ßÊÊÔÖ½ÌõÁéÃô¶È¸ß£¬ÅúÄڲÅú¼ä²îС£¬ÓнϺõÄÖØ¸´ÐÔ£¬¿Éͬʱ¼ì²âȫѪ¡¢ÑªÇ塢Ѫ½¬¡¢ÄòÒºÑù±¾£¬¶ÔÐÂà©ßʽøÐпìËÙ¶¨Á¿¼ì²â£¬¼«¾ßʵÓüÛÖµ¡£
Îĵµ±àºÅG01N33/558GK202166649SQ20112016176
¹«¿ªÈÕ2012Äê3ÔÂ14ÈÕ ÉêÇëÈÕÆÚ2011Äê5ÔÂ19ÈÕ ÓÅÏÈȨÈÕ2011Äê5ÔÂ19ÈÕ
·¢Ã÷ÕßÎâÜç, Íõº£òÔ, ʯÏþÇ¿, ÕÔÎÀ¹ú ÉêÇëÈË:²©ÑôÉúÎï¿Æ¼¼(ÉϺ£)ÓÐÏÞ¹«Ë¾

  • רÀûÃû³Æ£ºµ¼º½µç×ÓµØÍ¼µÀ·²î·Ö·½·¨¼°×°ÖõÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°µ¼º½¼¼ÊõÁìÓò£¬ÓÈÆäÉæ¼°Ò»ÖÖµ¼º½µç×ÓµØÍ¼µÀ·²î·Ö·½·¨¼°×°Öᣱ³¾°¼¼Êõ£ºÔÚµ¼º½µç×ÓµØÍ¼²úÆ·¿ª·¢ÖУ¬µÀ·²î·Ö·½·¨ÊÇÒ»ÖÖ³£ÓõIJúÆ·Æ·Öʼì²éÓë¿ØÖÆÊÖ ¶Î¡£½«´ý³öÆ·µÄµÀ·Êý¾ÝÓëÉÏÒ»°æ
  • רÀûÃû³Æ£º²£Á§±ßÔµ²âÁ¿×°ÖõÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖ²£Á§±ßÔµ²âÁ¿×°Öã¬ÓÈÖ¸¿ÉÀûÓùâÔ´·´ÉäµÄ·½Ê½À´Ìá¸ßÁÁ¶È¶Ô±È£¬Ê¹Ö®Äܸü׼ȷ²âÁ¿²£Á§»ù°åµ¹½Ç¾àÀëµÄ²âÁ¿×°Öᣱ³¾°¼¼Êõ£ºÒ»°ã²£Á§»ù°åÓÚ¼Ó¹¤Ê±£¬´ó¶àÐèҪͨ¹ý×Ô¶¯»¯»ų́À´×ö²£Á§±íÃæµÄÑÐÄ¥ÒÔ
  • רÀûÃû³Æ£ºÓÃÓÚÁúÃÅ¿ò¼ÜʽתÏò¼Ü²ÎÊý²âÊǪ̂¹¹¼Ü¶¨Î»¼Ð½ô×°ÖõÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°×ªÏò¼Ü²ÎÊý²âÊÔ¼ì²âÉ豸£¬ÌرðÊÇÉæ¼°Ò»ÖÖÓÃÓÚÁúÃÅ¿ò¼ÜʽתÏò¼Ü²ÎÊý²âÊǪ̂¹¹¼Ü¶¨Î»¼Ð½ô×°Öᣱ³¾°¼¼Êõ£º½üÄêÀ´£¬¿Í³µ¸ßËÙ»¯¡¢»õ³µÖØÔØ»¯·¢Õ¹ÒªÇ󣬶ÔÌúµÀ³µÁ¾¶¯Á¦Ñ§ÐÔ
  • רÀûÃû³Æ£º¾«Ãܵ¥µã¶¨Î»Óë¹ßÐÔ²âÁ¿½ô×éºÏµ¼º½ÏµÍ³µÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖµ¼º½ÏµÍ³£¬ÓÈÆäÊÇÒ»ÖÖÊÊÓÃÓÚÔËÊ乤¾ßµÄ¾«Ãܵ¥µã¶¨Î»Óë¹ßÐÔ²âÁ¿½ô×éºÏµ¼º½ÏµÍ³¡£±³¾°¼¼Êõ£ºÔËÊ乤¾ßµÄµ¼º½·ÖΪÁ½Àà¡£(1)×ÔÖ÷ʽµ¼º½Ó÷ÉÐÐÆ÷»ò´¬²°ÉϵÄÉ豸µ¼º½£¬Óйß
  • רÀûÃû³Æ£ºÊÔѹ½º¿éµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°©`ÖÖÊÔѹ½º¿é¡£±³¾°¼¼Êõ£ºÏÖÔÚPCCP¹ÜµÀÉú²úµÄ¹ý³ÌÖУ¬ÎªÁËÔڹܵÀ°²×°ºó·½±ã½ÓÍ·´òѹ£¬ÍùÍùÔÚ½½Öþ¥¨Ðòǰ½«Á½¡°U¡±Ðͽº¿é°ü¹üÔÚ²å¥í¶Ô³Æ´òѹÂÝË¿ÉÏ£¬ÔڹܵÀÉú²ú³ÉÐͺó£¬ÔÙ½«¡°U¡±Ðͽº¿éÈ¡³ö¡£¸Ã¼¼Êõ
  • רÀûÃû³Æ£ºÁ½Ä£¿é×éºÏÄÚ²ØÊ½½Â½Ó±íÏäµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖÓÃÓÚ°²×°È¼Æø±í¡¢Ë®±í»òµç±íµÄ±íÏä¡£±³¾°¼¼Êõ£ºÄ¿Ç°ÓÃÓÚ°²×°È¼Æø±í¡¢Ë®±í»òµç±íµÄ±íÏ䣬ÓÉÓÚÊǰ²×°ÔÚ»§Í⣬ÏäÌåÓëÏä¸ÇÁ¬½ÓµÄ½ÂÖáÒÔ¼°ÏäËøÈÝÒ×ÐâÊ´£¬ÈÕ¾ÃÌ쳤£¬Ôì³ÉÏä¸ÇÄÑÒÔ¿ªÆô£»ÓÉ
ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾
È«¹ú·þÎñÈÈÏߣº13062023238
µç»°£º13062023238
µØÖ·£ºëøÖÝÊÐÁúȪ¹¤ÒµÔ°68ºÅ
¹Ø¼ü´Ê£ºÏ³´²£¬Êý¿ØÏ³´²£¬ÁúÃÅϳ´²
¹«Ë¾¶þάÂë
Copyright 2010-2024 °æÈ¨ËùÓÐ All rights reserved ³ICP±¸19044495ºÅ-12
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿